Valuation — not yet established
No valuation for TMRW Life Sciences is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($198.3M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for TMRW Life Sciences
Create free account
No card required
Funding history
5 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Mar 2026 | Early Stage VC | $38.4M | ▮ | ▮ |
| Jun 2024 | Early Stage VC | $28.2M | ▮ | ▮ |
| Jun 2021 | Later Stage VC | $100.2M | ▮ | ▮ |
| Feb 2021 | Early Stage VC | $20.0M | ▮ | ▮ |
| Dec 2019 | Early Stage VC | $36.5M | ▮ | ▮ |
How TMRW Life Sciences's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For TMRW Life Sciences, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has TMRW Life Sciences raised?
- TMRW Life Sciences has raised $198.3M in total funding across 5 recorded rounds.
- When did TMRW Life Sciences last raise?
- TMRW Life Sciences last raised in Mar 2026 (Early Stage VC), raising $38.4M.